

Angelo receives prestigious AABB NBF Award for Innovative Research
For his work on Omics applications in Transfusion Medicine


Angelo receives prestigious ISBT Jean Julliard Award 2020
For his work on High-Throughput Metabolomics in Transfusion Medicine: towards personalized medicine


Attack on Red Blood Cells a Prime Suspect in COVID’s Debilitating Effects
CU Researcher’s own coronavirus illness helps inform studies on body’s oxygen transporters - by Chris Casey Angelo D’Alessandro, PhD,...


Tricking Mitochondria, the Cellular Powerhouse to Circumvent Chemotherapy Resistance
Researchers say, despite advancements in treatment, improving early therapy remains critical to cancer care - by Debra Melani Since a...


How Can Slumbering Squirrels Inform Astronauts on Long-term Journeys?
Researchers show the animals have uniquely adapted to their extreme habitat by converting bodily waste products into nutrients during...


Metabolomics: The Science Behind a two-times Tour de France Winner
CU research team’s platform measures how the body adapts during competition; has implications for treatments of cancer, diabetes,...


Follow us on Twitter and Facebook!!!
Starting December 2018 we moved to Twitter and Facebook for our most recent updates!!!


New effective drug combination for Acute Myeloid Leukemia
91% response rate to the combination of venetoclax with azacitidine in older adults newly diagnosed with acute myeloid leukemia (AML)"...


D'Alessandro receives NBF Scholar Award 2018
Original post at AABB.org - here Angelo D’Alessandro, PhD, will receive the title of National Blood Foundation Scholar during the NBF’s...


Discovery on T cell behavior has implications for cancer immunotherapy
Researchers find T cells elicited from subunit vaccines do not depend on glucose for reproduction Scientists at the University of...





